Sijibio Participates in Largest US Plastic Surgery Conference... First Local Unveiling of Human Tissue Skin Graft Materials

Acquired Quality Management Certification from the American Association of Organizational Banks

SGBio skin graft products: Sgiderm One Step, Sgiderm Matrix, SgiriAloperty.
[Photo by SGBio]

[Asia Economy Reporter Lee Gwan-joo] Sijibio recently participated in the American Society of Plastic Surgeons (PSTM 2022) held in Boston, USA, and on the 10th announced that it introduced its human tissue products, skin grafts 'Sijiderm One Step', 'Sijiderm Matrix', and 'Sijirialoperty', to the US market for the first time.

PSTM is a conference attended by more than 2,500 plastic surgeons from around the world every year and is the largest plastic surgery conference in the United States.

The products introduced by Sijibio this time are the only ones from a domestic company to have obtained quality management system certification from the American Association of Tissue Banks (AATB). Sijiderm One Step is an allogeneic dermal-derived reconstructive tissue matrix (RTM) skin graft that can be used in breast reconstruction surgery performed on patients who have undergone mastectomy.

Sijiderm Matrix and Sijirialoperty are skin grafts applying the micro collagen fiber (MCF) method, which finely grinds allogeneic dermal tissue and produces it in a mesh form. They can be used for skin reconstruction due to burns and trauma, and for breast-conserving surgery, respectively.

Along with this, the company stated that it has received proposals for joint research or business collaboration for the fully automated stromal vascular fraction (SVF) separation system derived from autologous fat, 'CellUnit (CELLUNIT)', and the vacuum-based breast massager 'Beluna (BELUNA)'.

CellUnit is a medical device that separates and purifies SVF from fat tissue extracted from the subject by medical staff using centrifugation, and can automatically perform all processes in 45 minutes with the push of a button. Beluna is a female-only breast massager developed based on the principle of providing a continuous stimulus to the tissue using vacuum pressure, supplying the nutrient pathways necessary for cell proliferation and differentiation.

Yu Hyun-seung, CEO of Sijibio, said, "It is very encouraging that most of the products exhibited at the largest plastic surgery conference in the United States received enthusiastic attention," adding, "In particular, as the only domestic company to have obtained AATB certification for human tissue products, we will strive to actively target overseas markets including the United States beyond Korea in the future."

This content was produced with the assistance of AI translation services.